Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.
暂无分享，去创建一个
Ding‐Shinn Chen | J. Kao | Chun-Jen Liu | Yi‐Hsiang Huang | Ming‐Lung Yu | R. Chien | Chao-Hung Hung | P. Cheng | C. Peng | Chung‐Feng Huang | Jee-Fu Huang | W. Chuang | C. Su | Chen‐Hua Liu | Chun‐Yen Lin | Pei‐Jer Chen | Shih-Jer Hsu | M. Yu | Jee‐Fu Huang | Chung-Feng Huang